Related Experiment Video
Updated: May 24, 2026
02:34
Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
Published on: May 10, 2024
Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation
1Wishaw Hospital, Department of Respiratory Medicine, 50 Netherton Road, Wishaw, Lanarkshire ML2 0DP, UK. manishpatel2@nhs.net
Expert Opinion on Pharmacotherapy
|February 28, 2012
Summary
Levosalbutamol, the (R)-isomer of salbutamol, shows beneficial effects in preclinical models for treating COPD. However, clinical studies have not consistently demonstrated its superiority over racemic salbutamol.
Area of Science:
- Pharmacology
- Respiratory Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant inflammatory airway disease causing morbidity and mortality.
- Beta2-adrenoceptor agonists (β2-agonists) are crucial for managing COPD-related breathlessness by promoting bronchodilation.
- Salbutamol, a β2-agonist, exists as (R)- and (S)- isomers, with current treatments often using racemic mixtures.
Purpose of the Study:
- To evaluate the therapeutic potential of (R)-salbutamol (levosalbutamol) in obstructive airway diseases.
- To investigate the cellular and experimental effects of (R)-salbutamol compared to its (S)-isomer and racemic mixtures.
Main Methods:
- Preclinical evaluation of (R)-salbutamol's β2-agonist activity at cellular and experimental levels.
- Assessment of the effects of (S)-salbutamol on airway disease models, including in vitro and experimental asthma.
Main Results:
- Preclinical data indicate (R)-salbutamol provides beneficial β2-agonist effects.
- (S)-salbutamol was shown to counteract the effects of (R)-salbutamol and induce asthma-like features in experimental models.
Conclusions:
- Despite strong preclinical evidence supporting (R)-salbutamol's efficacy, clinical trials have not consistently shown its superiority over racemic salbutamol for COPD treatment.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...